ࡱ> gif@ 9bjbjFF f,,1F4tF.n~~~~~YYY.......$ 0R]2B.YYYYYB.~~W.sssY ~~.sY.ss+h,~r y3bc ,H-m.0.,,2m2 ,FF2,XYYsYYYYYB.B.FFi FFCardiac Surgery Ischemic Heart Disease- perfusion demand deficit or mismatch. The heart is an end organ that perfuses the entire body with blood as well as itself. 80% of blood flow to the heart itself occurs during diastole. Causes of ischemic heart disease Atherosclerotic cardiovascular disease Valvular heart disease Vasculitis Congenital coronary anomalies Dissection of the Thoracic aorta Myocardial ischemia- very important to give aspirin for this reason Common Symptoms and Signs of Ischemic Heart Disease Respiratory changes Dyspnea Orthopnea Paroxysmal nocturnal dyspnea SOB Chest pain or discomfort Palpitations Fatigue Presyncope Syncope Changes in heart rate or blood pressure Anxiety, diaphoresis. Cyanosis or pallor may accompany any of the symptoms. Any combination is possible. Diagnostic Evaluation of Ischemic Heart Disease- If the index of clinical suspicion is high. Further diagnostic studies are necessary. ECG- look for changes acute and chronic Acute ECG changes may include, Q waves, ST segment elevations, T wave inversions, and QT prolongation Chronic forms of ischemia may produce similar ECG findings often coexisting with persistent chest pain Exercise stress testing Echocardiogram- can show wall hypertrophy and chamber size Left heart catheterization- dye contrast study remains the gold standard in the diagnosis of ischemic heart disease. Can help to determine if coronary artery or valvular heart disease is present. Ejection fraction- dye is injected into the left ventricular cavity to evaluate left ventricular function Treatment of Ischemic Heart Disease Medical management- CCB, BB, vasodilators Percutaneous transluminal coronary angioplasty (PTCA)- AKA- balloon angioplasty; with or without stent placement Typically performed in catheterization lab and is used more often than CABG 20-30% chance of recurrence; 1/3 reanastamosis Surgical treatment- coronary artery bypass grafting (CABG) Indications: include failure with medical management techniques, lab evidence of continued ischemia (ex. liver enzymes, ABG), ejection fraction <30-40%, continued exercise intolerance, Q wave infarction, evidence of more than mild ischemia, multi-vessel disease Complications Hypotension Hypovolemia Cardiac tamponade Heart failure Infection- pneumonia, urinary sepsis, superficial or deep infection in surgical wounds, mediastinitis Microembolization and stroke- occurs in about 1% of patients. In the elderly, incidence may increase to 6% to 8% Respiratory failure- especially in patients with underlying pulmonary disease Renal insufficiency or renal failure * Essentially all organ systems can be affected by complications of CABG and the physiologic disruptions associated with the heart-lung machine. The possibility of these complications contributed to the movement to explore less invasive methods of coronary revascularization without coronary pulmonary bypass. (CABG on the beating heart) Prognosis- at most major centers, the mortality rate is about 2% to 4% for patients who undergo CABG Minimally invasive CABG laparoscopic CABG- performed through a limited # of incisions without the sue of cardiopulmonary bypass More extensive revascularization is performed through a standard or modified sternotomy incision Advantages- decrease pain, shorter recovery period, decrease chance of wound infection Valvular Heart Disease Methods for repair have been available since the 50s and 60s. The invention of the heart/lung machine has increased patient survival. Mitral stenosis was among the first to be treated. Dr. Starr performed the first successful valve replacement surgery. Diagnosis of Valvular Heart Disease Non-invasive ECG- may be normal, suggestive of LVH, or repolarization changes Echocardiography or echo Doppler studies Invasive- cardiac catheterization- definitive diagnostic procedure Aortic Valve Disease- most common surgical valve lesion in developed countries Aortic stenosis- progressive, usually clinically silent until signs of CHF develop. CLASSIC TRIAD of symptoms (angina, heart failure, syncope) eventually without intervention. The mortality rate approaches 100% within 5 years of the onset of symptoms. These symptoms of failure may appear suddenly or gradually progress Causes of aortic stenosis History of rheumatic fever Progressive valvular calcification Congenital cause Signs and symptoms of aortic stenosis Systolic ejection murmur at the aortic area transmitting to the neck and apex. In severe cases, there may be a palpable left ventricular heave or thrill Angina pectoris Syncope SUDDENC DEATH- rarely the initial symptom in previously asymptomatic patients Treatment of aortic stenosis Valve replacement surgery should be offered to symptomatic patients Aortic regurgitation- symptoms can be silent, even in the presence of massive cardiac enlargement the patient may not develop significant symptoms Causes of aortic regurgitation Marfans syndrome Scarring from valvulitis of rheumatic heart disease Valvular damage from bacterial endocarditis * Acute regurgitation related to aortic dissection or acute bacterial endocarditis is poorly tolerated and can lead to death without early or even emergency treatment Signs and symptoms of aortic regurgitation Usually asymptomatic Soft, aortic diastolic murmur Exertional dyspnea and fatigue Angina or atypical chest pain PND or pulmonary edema Wide pulse pressure- elevated systolic and low diastolic pressure Treatment of aortic regurgitation Valve replacement surgery should be offered to symptomatic patients. Medical treatment with vasodilators and beta-blocker therapy may postpone the need for surgical intervention Mitral stenosis- among the 1st acquired heart diseases treated by surgery Causes of mitral stenosis Rheumatic heart disease- scarring Signs and symptoms of mitral stenosis Localized mid-diastolic low pitched murmur- because the valve is thickened, it opens in early diastole with an OPENING SNAP Fatigue of exertion PND and orthopnea as right heart failure progresses Long standing pulmonary venous hypertension may precipitate development of bronchial submucosal varices- rupture may cause hemoptysis Paroxysmal or chronic atrial fibrillation- rate MUSRT be controlled or may precipitate dyspnea or pulmonary edema Treatment of Mitral stenosis- indication include, uncontrollable pulmonary edema, limiting dyspnea and intermittent pulmonary edema, evidence of pulmonary hypertension with right ventricular hypertrophy or hemoptysis, limitation of activity despite ventricular rate control and medical therapy and recurrent systemic emboli despite anticoagulation with moderate or severe stenosis Open mitral commissurotomy- may be used if there is no significant concurrent regurgitation Valve replacement surgery should be offered to patients with significant valve distortion or calcification and when there is presence of stenosis and regurgitation Mitral Regurgitation- may be asymptomatic for many years or for life. Can lead to left sided heart failure. Causes of mitral regurgitation Connective tissue diseases/Marfans syndrome Infective endocarditis/rheumatic heart disease (mixed picture-s stenosis and regurgitation) Sub-valvular dysfunction- ruptured chordae tendinae Papillary muscle dysfunction following MI Myxomatous degeneration- myxoma- benign tumor composed of primitive connective tissue cells and stroma- rare cause of mitral regurgitation Signs and symptoms of mitral regurgitation Pansystolic murmur maximal at apex- may radiate to axilla, prominent 3rd heart sound may be heard Exertional dyspnea and fatigue, which may progress gradually over years May predispose to infective endocarditis Treatment of mitral regurgitation Early surgical intervention is necessary to prevent progressive and irreversible damage to the left ventricle; there is better preservation of left ventricular function if intact valve repair can be done. Vale replacement should be offered if repair is not possible Tricuspid Valve Disease- isolated disease of the tricuspid valve is rare. Usually, tricuspid disease is associated with pulmonary hypertension and concomitant mitral valve disease. May be isolated finding in IV drug users where tricuspid endocarditis is present. Causes of tricuspid valve disease- usually rheumatic in origin. Other causes may included, SLE, myxomatous degeneration, and congenital anomaly Signs and symptoms of tricuspid valve disease diastolic rumble along left sternal border identical to mitral stenosis Signs or right heart failure, right ventricular overload- including hepatomegaly, ascites, and dependent edema Treatment of tricuspid valve disease Excision of the valve without valve replacement can be achieved in the absence of pulmonary hypertension- use for patients with tricuspid endocarditis valve replacement surgery should be offered Heart valves - Must be careful not to sew in too tightly- can cause conduction problems - Replacement is not curative- replaces one disease for another Prosthetic endocarditis Thromboembolism Bioprosthetic deterioration around 10 years 2 types- mechanical and bioprosthetic Mechanical- 3 types- leaflet used most often; more durable and rarely require replacement Disadvantage is that they are noisy and require lifelong anticoagulation with coumadin If less than 70 years old the patient should be offered mechanical valve replacement Bioprosthetic- use if life expectancy 10 years of less or women who plan to have children use xenograft or homograft Xenograft- another species; least durable Homograft- cadaver; somewhat durable; lowest thrombogenicity and prosthetic endocarditis Autograft- repositioning of your own valves; somewhat durable; lowest thrombogenicity and prosthetic endocarditis Comparison of Prosthetic Heart Valves Mechanical ValvesBioprosthetic ValvesDurability+++/-Thromboembolism-+Obstruction in small sizes+-Calcification with age+-Calcification with dialysis+- Congenital Heart Disease Ventricular Septal Defect- most common congenital heart defect in muscular. Ventricular septal defects can occur anywhere in the muscular septum. They are classified by location. The lesion is acyanotic with increased pulmonary blood flow. Antibiotic prophylaxis is MANDATORY; these patients are at risk for infective endocarditis. Signs and symptoms of ventricular septal defect Adults may be asymptomatic if defect is small to moderate II- V/VI holosystolic murmur heard best at the 2nd and 3rd IC spaces along the sternal border, often associated with a systolic thrill Large defects are associated with early left ventricular failure Chronic, moderate left to right shunts may lead to pulmonary vascular disease and right sided failure Treatment of ventricular septal defect(s)- defects causing large shunts should be repaired using prosthetic patches Complications of ventricular septal defect repair- heart block may be produced by sutures. The AV node, bundle of His an/or RBB may be damaged by sutures placed too deeply Patent Ductus Arteriosus- second most common congenital heart defect- acyanotic with increased pulmonary blood flow. Antibiotic prophylaxis is MANDATORY due to increased risk of infective endocarditis Signs and symptoms of Patent Ductus Arteriosus Adults may be asymptomatic if defect is small or moderate Continuous rough machinery murmur in late systole heard best at the 1st and 2nd IC spaces along the left sternal border, may be associated with systolic thrill- usually not present unless left ventricular failure or pulmonary hypertension exists Treatment of Patent Ductus Arteriosus- in uncomplicated cases, surgical ligation with multiple ties. In large defects, the patent ductus may be divided and oversewn on the ends. You must protect the recurrent laryngeal nerve during this procedure to prevent loss of voice Atrial Septal Defect(s)- third most common congenital heart defect Signs and symptoms of atrial septal defects Usually asymptomatic until middle age I-III/VI systolic ejection murmur heard best at 2nd and 3rd IC space parasternally, with wide split of S2 that does not vary with breathing Exertional dyspnea if large defect and cardiac failure is present Treatment of atrial septal defect- elective surgical repair with a prosthetic patch is indicated for large defects at 3-5 years of age to protect against late pulmonary hypertension Complications of atrial septal defect repair- complete heart block if sutures placed to anchor the graft are placed too close to the conduction system in the atria. Other complication may include patch leaks and mitral regurgitation or stenosis Transplantation Must respect religious beliefs Someone must die ')   + , B C M N k l     " # , - I J M N O g h t u | } ! " J S d  DVmn俻ܻ讧仳ܳ hoY@hoY@ hoY@h& hoY@5hoY@hoY@5hoY@hoY@h&5 h 5h&h&5h&h~%5h h~%h& h&5 h~%5 h/5h~%h~%5>  , C N l    # - J N O h u }  & Fgd& & Fgd& & Fgd& & Fgd~% & Fgd~% & Fgd~%$a$gd~%9} " 7 Dn,[ & Fgd  & Fgd  & Fgd  & FgdoY@ & FgdoY@ & Fgd&gdoY@ & Fgd&n+,Z[moLM  013 88\ijgv»·¢h` ha;hS-5 hS-5hS-hS-5hS- hS-hS- h&5h p h ph phoY@hoY@5 hoY@5hoY@h 5h h 5h hoY@h hoY@5>M 1h !88\j & FgdS- & FgdS- & Fgd& & FgdS-$a$gd&gd& & Fgd  & Fgd gdoY@ & Fgd g76S*I[bh^hgdS- & Fgd`  & F @ 8`gd`  & FgdS- & FgdS- & FgdS- & Fgd&6756RS)*HIZ[VWxy*+:GItuFSfg ! ˿ha;ha;5ha;h` h` H*ha;h` 5hh` h` 5ha;hS-5h` h` hS-5hS-hS-hS-5HWy+uSg! "l"#|###$$ & Fgda; & Fgda; & Fgda; & Fgd`  & Fgd`  & Fgd`  & FgdS-! ""k"l"#$#{#|#####$$#$$$W$X$$$ % %8%9%%%%%%% & &-&.&7'8'Q''''?(@(A(F(((((E)F)))))p*q******6+7+^+++++ž hN!i5hm'hN!i hm'hm'hp: hp:5 h~5h~h~5h~ha;5 ha;5ha;ha;H*h~ha;ha;5ha;F$$X$$ %9%%% &.&8'@(((F)))q****6+7+O+ & Fgdm'`gdp:gd~ & Fgd~ & Fgd~ & Fgda; & Fgda; & Fgda;O+_++++ ,d,,.-X--#.I.J.\.q. $Ifgd~gd~ & Fgd~ & Fgd~ & Fgd~ & Fgdm'+++d,,,,--.-/-7-H-W-a-j----".#.H.I..,/./9/R/U/]/`/0&0^0_000011331333334444P6Q666666777!7q7r777ѽѹűűŪѽѹűűŪŢŢűűŢŢhp:hp:5 h hp:hp:hp:H*h&h h&5hp:hp:h&5 h h& h&5h~h~5 h~5 h~hm'hm' h~h~h~@q.r.}...tkkk $Ifgd~kd$$IflF,    t06    44 la.....tkkk $Ifgd~kdT$$IflF,    t06    44 la.....tkkk $Ifgd~kd$$IflF,    t06    44 la.....tkkk $Ifgd~kd$$IflF,    t06    44 la.....tkkk $Ifgd~kdP$$IflF,    t06    44 la....//_000tkf^^VNF & Fgdp: & Fgdm' & Fgd&$a$gd&gd& ^ gd~kd$$IflF,    t06    44 la0P111k2334I4A5Q6666r77k8`9p999 & Fgd& & Fgdp: & Fgdp:7j8k8_9p9999h~%hp:5 hp:hp: hp:5hp:hp:5hp:&1h:p&/ =!"h#$%? 01h:p / =!"h#$% P0) 01h:p / =!"h#$%? 01h:p / =!"h#$% P0? 01h:p / =!"h#$% P0) 01h:p / =!"h#$%? 01h:p` / =!"h#$% P0) 01h:p / =!"h#$%? 01h:pN!i/ =!"h#$% P0) 01h:p / =!"h#$%R$$If!vh5 5 5 #v :Vl t65 R$$If!vh5 5 5 #v :Vl t65 R$$If!vh5 5 5 #v :Vl t65 R$$If!vh5 5 5 #v :Vl t65 R$$If!vh5 5 5 #v :Vl t65 R$$If!vh5 5 5 #v :Vl t65 D@D NormalCJ_HaJmH nHsH tHDA@D Default Paragraph FontRi@R  Table Normal4 l4a (k@(No Listj@j ~ Table Grid7:V0O7##1 d (d id d d e Ae e e e ,CNl#-JNOhu}"7 Dn,[M 1 h ! 8 8\jg76S*I[bWy+uSg!l|$X 9 .8@ F!!!q""""6#7#O#_#### $d$$.%X%%#&I&J&\&q&r&}&&&&&&&&&&&&&&&&&&&&&&''_(((P)))k*++,I,A-Q....r//k0`1p11100 0 0`0 0 0 0 0 0 0`0 0 0`0 0 0 0 0`0 0 0 0 0 0 000 0 0" 0 0 0" 0" 0" 0 0 0  0  0n 0n 0  0[ 0[ 0 0 0 0 0 0 0 00 0[ 0  0  0  0h 00 0 0 08 0\ 0\ 08 0 0 0g`0 0 0@0 0g 0 0 0 0 0g 06 0 0 0* 0* 0*0 0 0b 0b 0b 0b 0b 0b 0 0W 0 0+ 0u 0+ 0 0 0 0 0 0+ 0 0 0 0 0| 0| 0| 0| 0| 0 0  0  0  0 0  0 08 08 0  0  08 0! 0!000`0 08  08  08 `0 0 0# 0# 0# 0# 0$ 0$ 0$00000000000000000000000000000 0 0' 0_( 0_( 0_( 0_( 0' 0' 0 0+ 0+ 0+ 0+ 0 0Q. 0. 0. 0. 0Q. 0Q. 0 0`1 0`1n! +79!$&)1} $$O+q......09 "#%'(*+,-./098@0(  B S  ?11MNNO"Dn,[ \6JRS*[WyuSgV{|X.8!!""7#^#_#####&&..`1111X*r30Mm:<8\16AƪGI5808^8`0o(. ^`hH. pLp^p`L5hH. @ @ ^@ `5hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.^`OJPJQJ^Jo(-^`OJQJ^Jo(hHopp^p`OJQJo(hH@ @ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHoPP^P`OJQJo(hH^`OJPJQJ^Jo(^`OJQJ^Jo(hHopp^p`OJQJo(hH@ @ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHoPP^P`OJQJo(hH808^8`05o(. ^`5hH. pLp^p`L5hH. @ @ ^@ `5hH. ^`5hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.808^8`05o(. ^`5hH. pLp^p`L5hH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.16AX*GI3m:?@ABCDEFGHIJKLMNOPQRSTUWXYZ[\]_`abcdehRoot Entry F𣐴3bjData 41Table<3WordDocumentfSummaryInformation(VDocumentSummaryInformation8^CompObjj  FMicrosoft Word Document MSWordDocWord.Document.89q